Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.
This study is looking at a new way to use a special type of scan, called a PET scan, to check on people who have had radiotherapy for head and neck cancer. After radiotherapy, it can sometimes be hard for doctors to tell if a lump or change on a scan is leftover cancer or just inflammation (swelling and irritation) caused by the treatment. This study uses an advanced version of the PET scan, called a 4D dynamic LAFOV FDG-PET, to hopefully make this distinction clearer. By understanding what's what, doctors can make better decisions about further treatment, avoiding unnecessary procedures if it's just inflammation, and ensuring any remaining cancer is caught early. It's a key step in making sure patients get the most accurate follow-up care.
At a glance
What is this study about?
When someone has radiotherapy for head and neck cancer, the treatment is designed to kill the cancer cells. After the treatment is finished, doctors need to check carefully to make sure the cancer is gone. They often do scans to look inside the body. However, sometimes these scans can be tricky to read. The radiotherapy itself can cause swelling and changes in the tissues, which can look similar to cancer that hasn't fully gone away.
This study is trying to make these checks much more accurate. It's using a very advanced type of body scan called a 4D dynamic LAFOV FDG-PET. This isn't just a standard scan; it's a newer version that looks at how certain substances move through the body over time. The idea is that leftover cancer cells and areas of inflammation (irritation from the treatment) behave differently, and this special scan might be able to pick up on those differences.
By helping doctors tell the difference between inflammation and actual cancer, this study aims to improve decisions about what happens next. If it's just inflammation, patients can avoid more tests or treatments they don't need. If it is cancer, then doctors can find it earlier and plan the best way to deal with it. This study is important because it could lead to clearer answers and better care for people after head and neck cancer treatment.
Key takeaways
- This study uses an advanced scan to improve cancer checks after radiotherapy.
- It aims to tell the difference between remaining cancer and treatment-related inflammation.
- This could lead to more accurate diagnosis and better treatment decisions.
- The study involves a special PET scan around 3 months after radiotherapy.
- It is for adults who have finished radiotherapy for head and neck cancer.
Who may be eligible?
To be part of this study, you need to be an adult, aged 18 or older. You must have been diagnosed with a type of cancer called head and neck squamous cell carcinoma and have recently finished a course of radiotherapy treatment aimed at curing your cancer. You also need to be suitable to have the special PET scan that is part of this study during your routine check-up, about three months after your treatment ended. Before joining, you will need to agree to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been treated for head and neck squamous cell carcinoma?
- Have you recently finished curative radiotherapy for your cancer?
- Are you able to have a PET scan for your 3-month check-up?
- Are you not pregnant or breastfeeding?
What does participation involve?
This study is observational, which means it involves an extra scan during your routine check-up. You won't be given any new medication as part of the study. The main part of taking part will be having a special PET scan, called a dynamic LAFOV FDG-PET, which will take place around three months after you finish your radiotherapy treatment for head and neck cancer. This scan is extra to your usual care and will help the researchers gather information. There aren't any specific study visits beyond your normal follow-up appointments where the scan would be performed. The total duration of your active participation would likely be around the time of this scan and its immediate follow-up to collect results.
Potential risks and benefits
Locations (1)
- CHU BrestVerified postcodeBrest, France· Recruiting
Common questions
What is a PET scan?
A PET scan is a type of imaging test that helps doctors see how your organs and tissues are working. It uses a small amount of a radioactive substance to highlight areas of activity in your body.
Why is this scan different from a regular PET scan?
This study uses a more advanced PET scan that can watch how things move in your body over time. This extra detail might help doctors better tell the difference between cancer and inflammation.
Will I get extra radiotherapy in this study?
No, this study does not involve any additional radiotherapy treatment. You must have already completed your radiotherapy before being considered for this study.
Who is paying for this study?
The information provided does not specify who is funding this research.
What if I decide not to participate?
Deciding not to participate is absolutely fine and will not affect your medical care or treatment in any way.
How to find out more
Ronan ABGRAL, Pr
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.